Navigation Links
Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
Date:4/7/2009

NEW YORK, April 7 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. ("Biostar" or the "Company") (OTC Bulletin Board: BSPM) today reported financial results for the 12 months ended December 31, 2008.

    Highlights for Year Ended December 31, 2008:

    -- Total net sales for the year were $33.9 million, up from $15.9 million
       for 2007.
    -- Net Income for the year increased 69% to $6,690,542 as compared to
       $3,963,524 in 2007.
    -- Completed acquisition of 8.6 acres land in Xi'an.  Construction of
       on-site raw material processing plant to commence in Q2.
    -- Launched the China Hepatitis Internet Hospital
       (http://www.zggbyy.com ), a multi-purpose site providing quality care,
       products and support to patients afflicted with hepatitis.

Overview

The Company reported revenue of $33,910,922 for the year ended December 31, 2008 as compared to $15,887,486 for 2007. Net Income for 2008 was $6,690,542, or $0.22 per share on a fully diluted basis, versus $3,963,524 and $0.19 per share, respectively, for 2007.

This increase in revenue and net income reflects an increase in sales of all five of Biostar's State Food and Drug Administration ("SFDA") approved drugs, most notably the Xin Aoxing Oleanolic Acid Capsule, the only SFDA- approved, over-the-counter (OTC) treatment for hepatitis B. The increase in sales is also attributed to the continued implementation of the Company's "Blue Sea" project, which markets products directly to consumers in rural China through retail pharmacies at higher retail prices. Domestic PRC customers account for 100% of Biostar's sales.

Ronghua Wang, Chairman and Chief Executive Officer of the Company, stated, "I am quite pleased with the Company's performance in 2008. Our targeted marketing programs and strategic pricing increases resulted in
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
2. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
3. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
4. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
5. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
6. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
7. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
8. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
9. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
10. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013 Rhythm announced today the results ... the company,s novel ghrelin agonist for the treatment of ... demonstrated that RM-131 significantly accelerates early gastric emptying and ... patients with diabetic gastroparesis. The findings were presented at ... Orlando and recently published in Clinical ...
(Date:5/20/2013)... Del. (PRWEB) May 20, 2013 ... 14 young faculty members to its 2013 Class ... years, the company will provide this outstanding international ... work in advancing basic science to meet global ... designed to help promising young and untenured research ...
(Date:5/20/2013)... In Early 2013, Dr. Ritchie Shoemaker, ... illnesses , announced his vision for creating a network ... protocol for treating Chronic Inflammatory Response Syndrome (CIRS). This ... achieve certification in the Shoemaker Protocol. , “Creating ... Shoemaker Protocol in other parts of the country, is ...
(Date:5/19/2013)... The JM Internet Group (web: jm-seo.org), a ... announced that the company's YouTube channel on SEO ... on YouTube. The company uses YouTube as a way ... training for small businesses with much success. , "I ... helpful for their SEO strategies", explained Jason McDonald, director ...
Breaking Biology Technology:Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 3DuPont Celebrates Scientific Innovation by Recognizing Young Professors 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 3Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2
... a failed terrorist attack in 2006, plane passengers have not ... airports, leaving some parched at the airport and others having ... in Germany is paving the way to eliminate this necessary ... in IOP Publishing,s Superconductor Science and Technology explains ...
... This release is available in German . ... the electromagnetic character of radio waves by Heinrich Hertz, wireless ... are applied to transmit more data within shorter periods of ... also be used for radio transmis-sion. So far, however, manufacture ...
... Inc. (TSX: ONC, NASDAQ: ONCY ) ("Oncolytics") announced ... Canadian Biosciences Corp. (BCBC), a privately held biotechnology company ... of a variety of conditions, including cancer. , Oncolytics ... BCBC in exchange for 200,000 common shares of Oncolytics. ...
Cached Biology Technology:0.2 second test for explosive liquids 2Smallest nanoantennas for high-speed data networks 2Smallest nanoantennas for high-speed data networks 3Oncolytics Biotech(R) Inc. Announces Investment in Private Biotechnology Company 2
(Date:5/17/2013)... Sustainable Global Logistics Operations) is aiming to cut CO2 ... intermodal loading systems and the boosting of intelligent systems ... with experience in the logistics sector and in supply ... a duration of three and a half years. , ... components and ontologies shared by the users, objects and ...
(Date:5/16/2013)... 17, 2013) Illustrating a commitment to the ... Gastroenterological Association (AGA) Research Foundation has announced the ... Fellowship Award recipients. Supported by the National Institute ... this new award helps underrepresented minority students to ... nutrition research. , "By establishing this new award, ...
(Date:5/16/2013)... decades, scientists have used ancient shorelines to predict the stability ... of a high shoreline from three million years ago, for ... were thought to be evidence of a high sea ... assumption has led many scientists to think that if the ... may do just the same in our modern, progressively warming ...
Breaking Biology News(10 mins):New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2World's biggest ice sheets likely more stable than previously believed 2
... tastes good in culinary dishes such as Rosemary chicken and ... for your brain. A collaborative group from the Burnham Institute ... in Japan, report that the herb rosemary contains an ingredient ... active ingredient in rosemary, known as carnosic acid (CA), can ...
... farming is the major factor responsible for the destruction ... Indonesia, Malaysia, Thailand, Myanmar, Bangladesh, India, and Sri Lanka, ... of Biogeography. Giri and other researchers used more ... mangrove forests of the region, to quantify the rates ...
... first used clinically, scientists can finally get a detailed, ... This receptor hails from a family of proteins called ... several of our senses, and the action of about ... known structure of a human GPCR, the work promises ...
Cached Biology News:Rosemary chicken protects your brain from free radicals 2Scientists unveil structure of molecular target of many drugs 2
...
Ku80 Antibody Shipping Temperature: HOT Storage Temperature: -20C...
UBC13 Antibody...
... reactive against the complex IV assembly factor SURF1. ... cultured cells. SURF1 is an important assembly factor ... participate in the folding of subunit II and ... SURF1, particularly ones that result in an absence ...
Biology Products: